The intersections between O-GlcNAcylation and phosphorylation: Implications for multiple signaling pathways

Journal of Cell Science

Volumn 123, Issue 1, 2010, Pages 13-22

  Zeidan, Quira ^a   Hart, Gerald W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crosstalk; Insulin; Neurodegeneration; O GlcNAcylation; Phosphorylation; Signal transduction; Transcription

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N ACETYLGLUCOSAMINYLTRANSFERASE; NEUROFILAMENT PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CELLULAR DISTRIBUTION; DEGENERATIVE DISEASE; GENE OVEREXPRESSION; HOMEOSTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; GLYCOSYLATION; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBSTRATE CYCLING; TRANSCRIPTIONAL ACTIVATION;

EID: 72449187655     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.053678     Document Type: Article

References (85)

1. Arnold, C. S., Johnson, G. V., Cole, R. N., Dong, D. L., Lee, M. and Hart, G. W. (1996). The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J. Biol. Chem. 271, 28741-28744.
2. Ball, L. E., Berkaw, M. N. and Buse, M. G. (2006). Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1. Mol. Cell Proteomics 5, 313-323.
3. Butkinaree, C., Cheung, W. D., Park, S., Park, K., Barber, M. and Hart, G. W. (2008). Characterization of beta-N-acetylglucosaminidase cleavage by caspase-3 during apoptosis. J. Biol. Chem. 283, 23557-23566.
4. Chalkley, R. J., Thalhammer, A., Schoepfer, R. and Burlingame, A. L. (2009). Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides. Proc. Natl. Acad. Sci. USA 106, 8894-8899.
5. Cheng, X., Cole, R. N., Zaia, J. and Hart, G. W. (2000). Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta. Biochemistry 39, 11609-11620.
6. Cheung, W. D. and Hart, G. W. (2008). AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation. J. Biol. Chem. 283, 13009-13020.
7. Cheung, W. D., Sakabe, K., Housley, M. P., Dias, W. B. and Hart, G. W. (2008). O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. J. Biol. Chem. 283, 33935-33941.
8. Chou, S. M. and Wang, H. S. (1997). Aberrant glycosylation/ phosphorylation in chromatolytic motoneurons of Werdnig-Hoffmann disease. J. Neurol. Sci. 152, 198-209.
9. Chou, T. Y., Dang, C. V. and Hart, G. W. (1995a). Glycosylation of the c-Myc transactivation domain. Proc. Natl. Acad. Sci. USA 92, 4417-4421.
10. Chou, T. Y., Hart, G. W. and Dang, C. V. (1995b). c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270, 18961-18965.
11. Comer, F. I. and Hart, G. W. (2000). O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. J. Biol. Chem. 275, 29179-29182.
12. Comer, F. I. and Hart, G. W. (2001). Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry 40, 7845-7852.
13. Comtesse, N., Maldener, E. and Meese, E. (2001). Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. Biochem. Biophys. Res. Commun. 283, 634-640.
14. Copeland, R. J., Bullen, J. W. and Hart, G. W. (2008). Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am. J. Physiol. Endocrinol. Metab. 295, E17-E28.
15. Deng, Y., Li, B., Liu, F., Iqbal, K., Grundke-Iqbal, I., Brandt, R. and Gong, C. X. (2008). Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease. FASEB J. 22, 138-145.
16. Dias, W. B., Cheung, W. D., Wang, Z. and Hart, G. W. (2009). Regulation of calcium/calmodulin-dependent kinase IV by O-glcnac modification. J. Biol. Chem. 284, 21327-21337.
17. Dong, D. L. and Hart, G. W. (1994). Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J. Biol. Chem. 269, 19321-19330.
18. Dong, D. L., Xu, Z. S., Chevrier, M. R., Cotter, R. J., Cleveland, D. W. and Hart, G. W. (1993). Glycosylation of mammalian neurofilaments. Localization of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides L and M. J. Biol. Chem. 268, 16679-16687.
19. Dong, D. L., Xu, Z. S., Hart, G. W. and Cleveland, D. W. (1996). Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H. J. Biol. Chem. 271, 20845-20852.
20. Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C. and Brownlee, M. (2001). Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108, 1341-1348.
21. Federici, M., Menghini, R., Mauriello, A., Hribal, M. L., Ferrelli, F., Lauro, D., Sbraccia, P., Spagnoli, L. G., Sesti, G. and Lauro, R. (2002). Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106, 466-472.
22. Forsythe, M. E., Love, D. C., Lazarus, B. D., Kim, E. J., Prinz, W. A., Ashwell, G., Krause, M. W. and Hanover, J. A. (2006). Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc. Natl. Acad. Sci. USA 103, 11952-11957.
23. Gambetta, M. C., Oktaba, K. and Muller, J. (2009). Essential role of the glycosyltransferase sxc/Ogt in polycomb repression. Science 325, 93-96.
24. Gao, Y., Wells, L., Comer, F. I., Parker, G. J. and Hart, G. W. (2001). Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J. Biol. Chem. 276, 9838-9845.
25. Goldstein, A. Y., Wang, X. and Schwarz, T. L. (2008). Axonal transport and the delivery of pre-synaptic components. Curr. Opin. Neurobiol. 18, 495-503.
26. Griffith, L. S. and Schmitz, B. (1999). O-linked N-acetylglucosamine levels in cerebellar neurons respond reciprocally to pertubations of phosphorylation. Eur. J. Biochem. 262, 824-831.
27. Griffith, L. S., Mathes, M. and Schmitz, B. (1995). Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine. J. Neurosci. Res. 41, 270-278.
28. Haltiwanger, R. S., Blomberg, M. A. and Hart, G. W. (1992). Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. J. Biol. Chem. 267, 9005-9013.
29. Hanover, J. A. (2001). Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J. 15, 1865-1876.
30. Hanover, J. A., Forsythe, M. E., Hennessey, P. T., Brodigan, T. M., Love, D. C., Ashwell, G. and Krause, M. (2005). A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout. Proc. Natl. Acad. Sci. USA 102, 11266-11271.
31. Hart, G. W. (1997). Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu. Rev. Biochem. 66, 315-335.
32. Hart, G. W., Housley, M. P. and Slawson, C. (2007). Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446, 1017-1022.
33. Holt, G. D. and Hart, G. W. (1986). The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J. Biol. Chem. 261, 8049-8057.
34. Holt, G. D., Snow, C. M., Senior, A., Haltiwanger, R. S., Gerace, L. and Hart, G. W. (1987). Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J. Cell Biol. 104, 1157-1164.
35. Housley, M. P., Udeshi, N. D., Rodgers, J. T., Shabanowitz, J., Puigserver, P., Hunt, D. F. and Hart, G. W. (2009). A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J. Biol. Chem. 284, 5148-5157.
36. Iyer, S. P. and Hart, G. W. (2003). Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity. J. Biol. Chem. 278, 24608-24616.
37. Iyer, S. P., Akimoto, Y. and Hart, G. W. (2003). Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase. J. Biol. Chem. 278, 5399-5409.
38. Jackson, S. P. and Tjian, R. (1988). O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell 55, 125-133.
39. Kamemura, K., Hayes, B. K., Comer, F. I. and Hart, G. W. (2002). Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J. Biol. Chem. 277, 19229-19235.
40. Kawauchi, K., Araki, K., Tobiume, K. and Tanaka, N. (2009). Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proc. Natl. Acad. Sci. USA 106, 3431-3436.
41. Kearse, K. P. and Hart, G. W. (1991). Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc. Natl. Acad. Sci. USA 88, 1701-1705.
42. Kelly, W. G. and Hart, G. W. (1989). Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin. Cell 57, 243-251.
43. Kelly, W. G., Dahmus, M. E. and Hart, G. W. (1993). RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J. Biol. Chem. 268, 10416-10424.
44. Khidekel, N., Ficarro, S. B., Clark, P. M., Bryan, M. C., Swaney, D. L., Rexach, J. E., Sun, Y. E., Coon, J. J., Peters, E. C. and Hsieh-Wilson, L. C. (2007). Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. Nat. Chem. Biol. 3, 339-348.
45. Klein, A. L., Berkaw, M. N., Buse, M. G. and Ball, L. E. (2009). O-GlcNAc modification of insulin receptor substrate-1 (IRS-1) occurs in close proximity to multiple SH2 domain binding motifs. Mol. Cell. Proteomics 8, 2733-2745.
46. Kreppel, L. K. and Hart, G. W. (1999). Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J. Biol. Chem. 274, 32015-32022.
47. Lefebvre, T., Alonso, C., Mahboub, S., Dupire, M. J., Zanetta, J. P., Caillet-Boudin, M. L. and Michalski, J. C. (1999). Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. Biochim. Biophys. Acta 1472, 71-81.
48. Li, X., Molina, H., Huang, H., Zhang, Y. Y., Liu, M., Qian, S. W., Slawson, C., Dias, W. B., Pandey, A., Hart, G. W. et al. (2009). O-linked N-acetylglucosamine modification on CCAAT enhancer-binding protein beta: role during adipocyte differentiation. J. Biol. Chem. 284, 19248-19254.
49. Liang, F. C., Chen, R. P., Lin, C. C., Huang, K. T. and Chan, S. I. (2006). Tuning the conformation properties of a peptide by glycosylation and phosphorylation. Biochem. Biophys. Res. Commun. 342, 482-488.
50. Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W. and Gong, C. X. (2004). O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101, 10804-10809.
51. Liu, F., Shi, J., Tanimukai, H., Gu, J., Gu, J., Grundke-Iqbal, I., Iqbal, K. and Gong, C. X. (2009). Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain 132, 1820-1832.
52. Ludemann, N., Clement, A., Hans, V. H., Leschik, J., Behl, C. and Brandt, R. (2005). O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS). J. Biol. Chem. 280, 31648-31658.
53. Macauley, M. S., Bubb, A. K., Martinez-Fleites, C., Davies, G. J. and Vocadlo, D. J. (2008). Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance. J. Biol. Chem. 283, 34687-34695.
54. Marshall, S., Nadeau, O. and Yamasaki, K. (2004). Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels. J. Biol. Chem. 279, 35313-35319.
55. Marz, P., Stetefeld, J., Bendfeldt, K., Nitsch, C., Reinstein, J., Shoeman, R. L., Dimitriades-Schmutz, B., Schwager, M., Leiser, D., Ozcan, S. et al. (2006). Ataxin-10 interacts with O-linked beta-N-acetylglucosamine transferase in the brain. J. Biol. Chem. 281, 20263-20270.
56. McClain, D. A. and Crook, E. D. (1996). Hexosamines and insulin resistance. Diabetes 45, 1003-1009.
57. Murphy, J. E., Hanover, J. A., Froehlich, M., DuBois, G. and Keen, J. H. (1994). Clathrin assembly protein AP-3 is phosphorylated and glycosylated on the 50-kDa structural domain. J. Biol. Chem. 269, 21346-21352.
58. Musicki, B., Kramer, M. F., Becker, R. E. and Burnett, A. L. (2005). Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc. Natl. Acad. Sci. USA 102, 11870-11875.
59. O'Donnell, N., Zachara, N. E., Hart, G. W. and Marth, J. D. (2004). Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol. Cell. Biol. 24, 1680-1690.
60. Park, S. Y., Ryu, J. and Lee, W. (2005). O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes. Exp. Mol. Med. 37, 220-229.
61. Previato, J. O., Jones, C., Goncalves, L. P., Wait, R., Travassos, L. R. and Mendonca-Previato, L. (1994). O-glycosidically linked N-acetylglucosamine-bound oligosaccharides from glycoproteins of Trypanosoma cruzi. Biochem. J. 301, 151-159.
62. Robinson, K. A., Ball, L. E. and Buse, M. G. (2007). Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 292, E884-E890.
63. Schultz, J. and Pils, B. (2002). Prediction of structure and functional residues for O-GlcNAcase, a divergent homologue of acetyltransferases. FEBS Lett. 529, 179-182.
64. Shafi, R., Iyer, S. P., Ellies, L. G., O'Donnell, N., Marek, K. W., Chui, D., Hart, G. W. and Marth, J. D. (2000). The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. USA 97, 5735-5739.
65. Sinclair, D. A., Syrzycka, M., Macauley, M. S., Rastgardani, T., Komljenovic, I., Vocadlo, D. J., Brock, H. W. and Honda, B. M. (2009). Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc). Proc. Natl. Acad. Sci. USA 106, 13427-13432.
66. Slawson, C., Zachara, N. E., Vosseller, K., Cheung, W. D., Lane, M. D. and Hart, G. W. (2005). Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J. Biol. Chem. 280, 32944-32956.
67. Slawson, C., Lakshmanan, T., Knapp, S. and Hart, G. W. (2008). A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. Mol. Biol. Cell 19, 4130-4140.
68. Toleman, C., Paterson, A. J., Whisenhunt, T. R. and Kudlow, J. E. (2004). Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities. J. Biol. Chem. 279, 53665-53673.
69. Torres, C. R. and Hart, G. W. (1984). Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259, 3308-3317.
70. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A. et al. (2001). The sequence of the human genome. Science 291, 1304-1351.
71. Vosseller, K., Wells, L., Lane, M. D. and Hart, G. W. (2002). Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 99, 5313-5318.
72. Wang, Z., Pandey, A. and Hart, G. W. (2007). Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. Mol. Cell Proteomics 6, 1365-1379.
73. Wang, Z., Park, K., Comer, F., Hsieh-Wilson, L. C., Saudek, C. D. and Hart, G. W. (2009). Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes. Diabetes 58, 309-317.
74. Wells, L., Gao, Y., Mahoney, J. A., Vosseller, K., Chen, C., Rosen, A. and Hart, G. W. (2002a). Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. J. Biol. Chem. 277, 1755-1761.
75. Wells, L., Vosseller, K., Cole, R. N., Cronshaw, J. M., Matunis, M. J. and Hart, G. W. (2002b). Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol. Cell. Proteomics 1, 791-804.
76. Wells, L., Kreppel, L. K., Comer, F. I., Wadzinski, B. E. and Hart, G. W. (2004). O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. J. Biol. Chem. 279, 38466-38470.
77. Whelan, S. A., Lane, M. D. and Hart, G. W. (2008). Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling. J. Biol. Chem. 283, 21411-21417.
78. Whisenhunt, T. R., Yang, X., Bowe, D. B., Paterson, A. J., Van Tine, B. A. and Kudlow, J. E. (2006). Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 16, 551-563.
79. Wu, W.-G., Pasternack, L., Huang, D.-H., Koeller, K. M., Lin, C.-C., Seitz, O. and Wong, C.-H. (1999). Structural study on O-glycopeptides: glycosylation-induced conformational changes of O-GlcNAc, O-LacNAc, O-Sialyl-LacNAc, and O-Sialyl-Lewis-X peptides of the mucin domain of MAdCAM-1. J. Am. Chem. Soc. 121, 2409-2417.
80. Yang, W. H., Kim, J. E., Nam, H. W., Ju, J. W., Kim, H. S., Kim, Y. S. and Cho, J. W. (2006). Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 8, 1074-1083.
81. Yang, X., Ongusaha, P. P., Miles, P. D., Havstad, J. C., Zhang, F., So, W. V., Kudlow, J. E., Michell, R. H., Olefsky, J. M., Field, S. J. et al. (2008). Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451, 964-969.
82. Yao, P. J. and Coleman, P. D. (1998a). Reduced O-glycosylated clathrin assembly protein AP180: implication for synaptic vesicle recycling dysfunction in Alzheimer's disease. Neurosci. Lett. 252, 33-36.
83. Yao, P. J. and Coleman, P. D. (1998b). Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease. J. Neurosci. 18, 2399-2411.
84. Yuzwa, S. A., Macauley, M. S., Heinonen, J. E., Shan, X., Dennis, R. J., He, Y., Whitworth, G. E., Stubbs, K. A., McEachern, E. J., Davies, G. J. et al. (2008). A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 4, 483-490.
85. Zachara, N. E., O'Donnell, N., Cheung, W. D., Mercer, J. J., Marth, J. D. and Hart, G. W. (2004). Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J. Biol. Chem. 279, 30133-30142.